Expanding The Boundaries
of Cytokine BIology

At Bright Peak we are creating innovative cytokine therapeutics that are uniquely engineered to precisely control and expand desired biological properties.

More About Us

Using our proprietary Enhanced Design and Combine (EDC) chemistry platform, we are developing an emerging portfolio of novel designer immunotherapies for the treatment of cancer and autoimmune diseases.
Through our EDC platform we are also pioneering a new category of “Bright Peak Immunocytokines” that simultaneously leverages the precision of antibody targeting with cytokine-mediated selective immune modulation in the desired microenvironment.

More About Our Science